Tissue Regenix Group plc (LON:TRX – Get Free Report)’s share price passed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 60.55 ($0.76) and traded as low as GBX 57 ($0.71). Tissue Regenix Group shares last traded at GBX 57 ($0.71), with a volume of 18,582 shares.
Tissue Regenix Group Stock Performance
The company has a debt-to-equity ratio of 35.69, a current ratio of 3.74 and a quick ratio of 2.36. The firm has a fifty day simple moving average of GBX 58.80 and a 200 day simple moving average of GBX 60.55. The company has a market capitalization of £40.60 million, a price-to-earnings ratio of -5,700.00 and a beta of 1.61.
About Tissue Regenix Group
Tissue Regenix is a leading medical device company in regenerative medicine. The Company’s patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient’s body that can be used to repair diseased or damaged body structures.
Read More
- Five stocks we like better than Tissue Regenix Group
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- What Are Dividend Challengers?
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- Want to Profit on the Downtrend? Downtrends, Explained.
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
